Cargando…
Hormonal Contraception, Pregnancy, Breastfeeding, and Risk of HIV Disease Progression Among Zambian Women
BACKGROUND: Some studies suggest that hormonal contraception, pregnancy, and/or breastfeeding may influence rates of HIV disease progression. METHODS: From 1994 to 2012, HIV discordant couples recruited at couples' voluntary HIV counseling and testing centers in Lusaka were followed 3-monthly....
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JAIDS Journal of Acquired Immune Deficiency Syndromes
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752415/ https://www.ncbi.nlm.nih.gov/pubmed/26379070 http://dx.doi.org/10.1097/QAI.0000000000000848 |
_version_ | 1782415723526619136 |
---|---|
author | Wall, Kristin M. Kilembe, William Haddad, Lisa Vwalika, Bellington Lakhi, Shabir Khu, Naw Htee Brill, Ilene Chomba, Elwyn Mulenga, Joseph Tichacek, Amanda Allen, Susan |
author_facet | Wall, Kristin M. Kilembe, William Haddad, Lisa Vwalika, Bellington Lakhi, Shabir Khu, Naw Htee Brill, Ilene Chomba, Elwyn Mulenga, Joseph Tichacek, Amanda Allen, Susan |
author_sort | Wall, Kristin M. |
collection | PubMed |
description | BACKGROUND: Some studies suggest that hormonal contraception, pregnancy, and/or breastfeeding may influence rates of HIV disease progression. METHODS: From 1994 to 2012, HIV discordant couples recruited at couples' voluntary HIV counseling and testing centers in Lusaka were followed 3-monthly. Multivariate survival analyses explored associations between time-varying contraception, pregnancy, and breastfeeding and 2 outcomes among HIV-positive women: (1) time to death and (2) time to antiretroviral treatment (ART) initiation. RESULTS: Among 1656 female seropositive, male seronegative couples followed for 3359 person-years (PY), 224 women died [6.7/100 PY; 95% confidence interval (CI): 5.8 to 7.6]. After 2003, 290 women initiated ART (14.5/100 PY; 95% CI: 12.9 to 16.2). In a multivariate model of time to death, hormonal implant [adjusted hazard ratio (aHR) = 0.30; 95% CI: 0.10 to 0.98] and injectable (aHR = 0.59; 95% CI: 0.36 to 0.97) were significantly protective relative to nonhormonal method use, whereas oral contraceptive pill (OCP) use was not (aHR = 1.08; 95% CI: 0.74 to 1.57) controlling for baseline HIV disease stage, time-varying pregnancy, time-varying breastfeeding, and year of enrollment. In a multivariate model of time-to-ART initiation, implant was significantly protective (aHR = 0.54; 95% CI: 0.31 to 0.95), whereas OCP (aHR = 0.70; 95% CI: 0.44 to 1.10) and injectable (aHR = 0.85; 95% CI: 0.55 to 1.32) were not relative to nonhormonal method use controlling for variables above, woman's age, and literacy. Pregnancy was not significantly associated with death (aHR = 1.07; 95% CI: 0.68 to 1.66) or ART initiation (aHR = 1.24; 95% CI: 0.83 to 1.86), whereas breastfeeding was protective for death (aHR = 0.34; 95% CI: 0.19 to 0.62) and ART initiation (aHR = 0.49; 95% CI: 0.29 to 0.85). CONCLUSIONS: Hormonal implants and injectables significantly predicted lower mortality; implants were protective for ART initiation. OCPs and pregnancy were not associated with death or ART initiation, whereas breastfeeding was protective for both. Findings from this 18-year cohort study suggest that (1) HIV-positive women desiring pregnancy can be counseled to do so and breastfeed and (2) all effective contraceptive methods, including injectables and implants, should be promoted to prevent unintended pregnancy. |
format | Online Article Text |
id | pubmed-4752415 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | JAIDS Journal of Acquired Immune Deficiency Syndromes |
record_format | MEDLINE/PubMed |
spelling | pubmed-47524152016-03-19 Hormonal Contraception, Pregnancy, Breastfeeding, and Risk of HIV Disease Progression Among Zambian Women Wall, Kristin M. Kilembe, William Haddad, Lisa Vwalika, Bellington Lakhi, Shabir Khu, Naw Htee Brill, Ilene Chomba, Elwyn Mulenga, Joseph Tichacek, Amanda Allen, Susan J Acquir Immune Defic Syndr Epidemiology and Prevention BACKGROUND: Some studies suggest that hormonal contraception, pregnancy, and/or breastfeeding may influence rates of HIV disease progression. METHODS: From 1994 to 2012, HIV discordant couples recruited at couples' voluntary HIV counseling and testing centers in Lusaka were followed 3-monthly. Multivariate survival analyses explored associations between time-varying contraception, pregnancy, and breastfeeding and 2 outcomes among HIV-positive women: (1) time to death and (2) time to antiretroviral treatment (ART) initiation. RESULTS: Among 1656 female seropositive, male seronegative couples followed for 3359 person-years (PY), 224 women died [6.7/100 PY; 95% confidence interval (CI): 5.8 to 7.6]. After 2003, 290 women initiated ART (14.5/100 PY; 95% CI: 12.9 to 16.2). In a multivariate model of time to death, hormonal implant [adjusted hazard ratio (aHR) = 0.30; 95% CI: 0.10 to 0.98] and injectable (aHR = 0.59; 95% CI: 0.36 to 0.97) were significantly protective relative to nonhormonal method use, whereas oral contraceptive pill (OCP) use was not (aHR = 1.08; 95% CI: 0.74 to 1.57) controlling for baseline HIV disease stage, time-varying pregnancy, time-varying breastfeeding, and year of enrollment. In a multivariate model of time-to-ART initiation, implant was significantly protective (aHR = 0.54; 95% CI: 0.31 to 0.95), whereas OCP (aHR = 0.70; 95% CI: 0.44 to 1.10) and injectable (aHR = 0.85; 95% CI: 0.55 to 1.32) were not relative to nonhormonal method use controlling for variables above, woman's age, and literacy. Pregnancy was not significantly associated with death (aHR = 1.07; 95% CI: 0.68 to 1.66) or ART initiation (aHR = 1.24; 95% CI: 0.83 to 1.86), whereas breastfeeding was protective for death (aHR = 0.34; 95% CI: 0.19 to 0.62) and ART initiation (aHR = 0.49; 95% CI: 0.29 to 0.85). CONCLUSIONS: Hormonal implants and injectables significantly predicted lower mortality; implants were protective for ART initiation. OCPs and pregnancy were not associated with death or ART initiation, whereas breastfeeding was protective for both. Findings from this 18-year cohort study suggest that (1) HIV-positive women desiring pregnancy can be counseled to do so and breastfeed and (2) all effective contraceptive methods, including injectables and implants, should be promoted to prevent unintended pregnancy. JAIDS Journal of Acquired Immune Deficiency Syndromes 2016-03-01 2016-02-10 /pmc/articles/PMC4752415/ /pubmed/26379070 http://dx.doi.org/10.1097/QAI.0000000000000848 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. |
spellingShingle | Epidemiology and Prevention Wall, Kristin M. Kilembe, William Haddad, Lisa Vwalika, Bellington Lakhi, Shabir Khu, Naw Htee Brill, Ilene Chomba, Elwyn Mulenga, Joseph Tichacek, Amanda Allen, Susan Hormonal Contraception, Pregnancy, Breastfeeding, and Risk of HIV Disease Progression Among Zambian Women |
title | Hormonal Contraception, Pregnancy, Breastfeeding, and Risk of HIV Disease Progression Among Zambian Women |
title_full | Hormonal Contraception, Pregnancy, Breastfeeding, and Risk of HIV Disease Progression Among Zambian Women |
title_fullStr | Hormonal Contraception, Pregnancy, Breastfeeding, and Risk of HIV Disease Progression Among Zambian Women |
title_full_unstemmed | Hormonal Contraception, Pregnancy, Breastfeeding, and Risk of HIV Disease Progression Among Zambian Women |
title_short | Hormonal Contraception, Pregnancy, Breastfeeding, and Risk of HIV Disease Progression Among Zambian Women |
title_sort | hormonal contraception, pregnancy, breastfeeding, and risk of hiv disease progression among zambian women |
topic | Epidemiology and Prevention |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752415/ https://www.ncbi.nlm.nih.gov/pubmed/26379070 http://dx.doi.org/10.1097/QAI.0000000000000848 |
work_keys_str_mv | AT wallkristinm hormonalcontraceptionpregnancybreastfeedingandriskofhivdiseaseprogressionamongzambianwomen AT kilembewilliam hormonalcontraceptionpregnancybreastfeedingandriskofhivdiseaseprogressionamongzambianwomen AT haddadlisa hormonalcontraceptionpregnancybreastfeedingandriskofhivdiseaseprogressionamongzambianwomen AT vwalikabellington hormonalcontraceptionpregnancybreastfeedingandriskofhivdiseaseprogressionamongzambianwomen AT lakhishabir hormonalcontraceptionpregnancybreastfeedingandriskofhivdiseaseprogressionamongzambianwomen AT khunawhtee hormonalcontraceptionpregnancybreastfeedingandriskofhivdiseaseprogressionamongzambianwomen AT brillilene hormonalcontraceptionpregnancybreastfeedingandriskofhivdiseaseprogressionamongzambianwomen AT chombaelwyn hormonalcontraceptionpregnancybreastfeedingandriskofhivdiseaseprogressionamongzambianwomen AT mulengajoseph hormonalcontraceptionpregnancybreastfeedingandriskofhivdiseaseprogressionamongzambianwomen AT tichacekamanda hormonalcontraceptionpregnancybreastfeedingandriskofhivdiseaseprogressionamongzambianwomen AT allensusan hormonalcontraceptionpregnancybreastfeedingandriskofhivdiseaseprogressionamongzambianwomen |